A New Look at Summit Therapeutics Inc (SMMT) Stock’s Hidden Strategies

Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $27. The stock was initiated by BTIG Research, who […]

Will Earnings Beat Estimates? Summit Therapeutics Inc (SMMT) Stock

Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $27. The stock was initiated by BTIG Research, who […]

What does the future hold for Summit Therapeutics Inc (SMMT) Stock?

Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $27. The stock was initiated by BTIG Research, who […]

A Real Picture of Summit Therapeutics Inc (SMMT) Stock: The Fundamentals

Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $27. The stock was initiated by BTIG Research, who […]

The performance of Summit Therapeutics Inc (SMMT) Stock has improved

Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $27. The stock was initiated by BTIG Research, who […]

Why Summit Therapeutics Inc (NASDAQ:SMMT) Stock up 0.22% in Last Week?

Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. The research report from Needham has reiterated the stock to Buy, with a price target set at $27. The stock was initiated by BTIG Research, who […]

Does Summit Therapeutics Inc (SMMT) Stock have a positive outlook following recent trade?

Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]

Where are Investors’ Sentiments? Summit Therapeutics Inc (SMMT) Stock

Janney raised the price target for the Summit Therapeutics Inc (NASDAQ:SMMT) stock from “a Buy” to “a Neutral”. The rating was released on June 28, 2018, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]